Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 23341059)

1.

Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy.

Wang H, Wu Y, Zhao R, Nie G.

Adv Mater. 2013 Mar 20;25(11):1616-22. doi: 10.1002/adma.201204750. Epub 2013 Jan 22.

PMID:
23341059
2.

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.

Wang H, Zhao Y, Wu Y, Hu YL, Nan K, Nie G, Chen H.

Biomaterials. 2011 Nov;32(32):8281-90. doi: 10.1016/j.biomaterials.2011.07.032. Epub 2011 Jul 31.

PMID:
21807411
3.

Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.

Ma Q, Li B, Yu Y, Zhang Y, Wu Y, Ren W, Zheng Y, He J, Xie Y, Song X, He G.

Int J Pharm. 2013 Mar 10;445(1-2):88-92. doi: 10.1016/j.ijpharm.2013.01.046. Epub 2013 Jan 31.

PMID:
23376505
4.

Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs.

Xiao H, Stefanick JF, Jia X, Jing X, Kiziltepe T, Zhang Y, Bilgicer B.

Chem Commun (Camb). 2013 May 25;49(42):4809-11. doi: 10.1039/c3cc39119a.

PMID:
23595166
5.

Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.

Wang G, Yu B, Wu Y, Huang B, Yuan Y, Liu CS.

Int J Pharm. 2013 Mar 25;446(1-2):24-33. doi: 10.1016/j.ijpharm.2013.02.004. Epub 2013 Feb 10.

PMID:
23402977
6.

The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice.

Upadhyay KK, Mishra AK, Chuttani K, Kaul A, Schatz C, Le Meins JF, Misra A, Lecommandoux S.

Nanomedicine. 2012 Jan;8(1):71-80. doi: 10.1016/j.nano.2011.05.008. Epub 2011 Jun 22.

PMID:
21703363
7.

Hexagonal prism nanocarriers for mitigated phagocytosis.

Park K.

J Control Release. 2011 Aug 25;154(1):1. doi: 10.1016/j.jconrel.2011.07.020. Epub 2011 Jul 19. No abstract available.

PMID:
21771619
8.

Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.

Taratula O, Kuzmov A, Shah M, Garbuzenko OB, Minko T.

J Control Release. 2013 Nov 10;171(3):349-57. doi: 10.1016/j.jconrel.2013.04.018. Epub 2013 May 3.

9.

Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.

Rafi M, Cabral H, Kano MR, Mi P, Iwata C, Yashiro M, Hirakawa K, Miyazono K, Nishiyama N, Kataoka K.

J Control Release. 2012 Apr 30;159(2):189-96. doi: 10.1016/j.jconrel.2012.01.038. Epub 2012 Feb 3.

PMID:
22326402
10.
11.

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

Gong C, Xie Y, Wu Q, Wang Y, Deng S, Xiong D, Liu L, Xiang M, Qian Z, Wei Y.

Nanoscale. 2012 Sep 28;4(19):6004-17. doi: 10.1039/c2nr31517c. Epub 2012 Aug 22.

PMID:
22910790
12.

Nanocarriers for anticancer drugs--new trends in nanomedicine.

Drbohlavova J, Chomoucka J, Adam V, Ryvolova M, Eckschlager T, Hubalek J, Kizek R.

Curr Drug Metab. 2013 Jun;14(5):547-64. Review.

PMID:
23687925
13.

Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.

Han S, Liu Y, Nie X, Xu Q, Jiao F, Li W, Zhao Y, Wu Y, Chen C.

Small. 2012 May 21;8(10):1596-606. doi: 10.1002/smll.201102280. Epub 2012 Mar 13.

PMID:
22411637
14.

Targeting liposomes toward novel pediatric anticancer therapeutics.

Federman N, Denny CT.

Pediatr Res. 2010 May;67(5):514-9. doi: 10.1203/PDR.0b013e3181d601c5. Review.

PMID:
20118828
15.

Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.

Shieh MJ, Hsu CY, Huang LY, Chen HY, Huang FH, Lai PS.

J Control Release. 2011 Jun 30;152(3):418-25. doi: 10.1016/j.jconrel.2011.03.017. Epub 2011 Mar 22.

PMID:
21435362
16.

Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.

Huang S, Shao K, Liu Y, Kuang Y, Li J, An S, Guo Y, Ma H, Jiang C.

ACS Nano. 2013 Mar 26;7(3):2860-71. doi: 10.1021/nn400548g. Epub 2013 Mar 12.

PMID:
23451830
17.

Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.

Markovsky E, Baabur-Cohen H, Satchi-Fainaro R.

J Control Release. 2014 Aug 10;187:145-57. doi: 10.1016/j.jconrel.2014.05.025. Epub 2014 May 24.

PMID:
24862318
18.

Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.

Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L.

J Control Release. 2010 Jul 1;145(1):17-25. doi: 10.1016/j.jconrel.2010.03.007. Epub 2010 Mar 20.

PMID:
20307599
19.

Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery.

Jia Y, Yuan M, Yuan H, Huang X, Sui X, Cui X, Tang F, Peng J, Chen J, Lu S, Xu W, Zhang L, Guo Q.

Int J Nanomedicine. 2012;7:1697-708. doi: 10.2147/IJN.S28629. Epub 2012 Mar 28.

20.

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T.

J Control Release. 2008 Sep 10;130(2):107-14. doi: 10.1016/j.jconrel.2008.05.024. Epub 2008 Jun 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk